Abivax (ABVX) Non-Current Assets (2022 - 2026)

Abivax's Non-Current Assets history runs 5 years deep, the most recent figure standing at $39.7 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 10.16% year-over-year to $39.7 million; the TTM figure through Mar 2026 stood at $39.7 million (up 10.16% YoY), while the FY2025 annual figure was $38.5 million, up 4.2% from the prior year.
• Non-Current Assets was $39.7 million for Q1 2026 at Abivax, up from $38.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $44.7 million in Q2 2024 to a low of $36.1 million in Q1 2025.
• Historically, Non-Current Assets has averaged $39.6 million across 5 years, with a median of $38.5 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets fell 16.37% in 2024, then increased 10.16% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $40.2 million in 2022, then advanced by 10.09% to $44.2 million in 2023, then dropped by 16.37% to $37.0 million in 2024, then advanced by 4.2% to $38.5 million in 2025, then grew by 3.08% to $39.7 million in 2026.
• The last three Non-Current Assets figures came in at $39.7 million (Q1 2026), $38.5 million (Q4 2025), and $38.3 million (Q3 2025), per Business Quant data.